Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Oncology Reports
|
June 28, 2026
Anti-PD-1 Combinations: Triplets and Beyond
Claudia Trojaniello, Antonella Lucia Marretta, Bianca Arianna Facchini, et al.
Journal of Clinical Medicine
|
February 25, 2023
Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
Antonella Lucia Marretta, Alessandro Ottaiano, Domenico Iervolino, et al.
Pharmaceutics
|
September 28, 2021
Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
Antonella Lucia Marretta, Giuseppe Di Lorenzo, Dario Ribera, et al.
Frontiers in Endocrinology
|
October 15, 2025
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors
Erica Pietroluongo, Antonella Lucia Marretta, Mauro Cives, et al.
Journal of Translational Medicine
|
February 3, 2026
A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
Fernanda Picozzi, Alessandro Ottaiano, Antonella Lucia Marretta, et al.
Cells
|
June 28, 2023
The Impact of O6-Methylguanine-DNA Methyltransferase (<i>MGMT</i>) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine
Lucia Cannella, Rosa Della Monica, Antonella Lucia Marretta, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, et al.
Frontiers in Genetics
|
December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
Sara Parola, Christoph Oing, Pasquale Rescigno, et al.
Clinical Genitourinary Cancer
|
May 7, 2021
Assessment of Total, PTEN<sup>-</sup>, and AR-V7<sup>+</sup> Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
Giuseppe Di Lorenzo, Silvia Zappavigna, Felice Crocetto, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2020
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
Margaret Ottaviano, Marcello Curvietto, Pasquale Rescigno, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Oncology Reports
|
June 28, 2026
Anti-PD-1 Combinations: Triplets and Beyond
Claudia Trojaniello, Antonella Lucia Marretta, Bianca Arianna Facchini, et al.
Journal of Clinical Medicine
|
February 25, 2023
Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
Antonella Lucia Marretta, Alessandro Ottaiano, Domenico Iervolino, et al.
Pharmaceutics
|
September 28, 2021
Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
Antonella Lucia Marretta, Giuseppe Di Lorenzo, Dario Ribera, et al.
Frontiers in Endocrinology
|
October 15, 2025
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors
Erica Pietroluongo, Antonella Lucia Marretta, Mauro Cives, et al.
Journal of Translational Medicine
|
February 3, 2026
A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
Fernanda Picozzi, Alessandro Ottaiano, Antonella Lucia Marretta, et al.
Cells
|
June 28, 2023
The Impact of O6-Methylguanine-DNA Methyltransferase (<i>MGMT</i>) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine
Lucia Cannella, Rosa Della Monica, Antonella Lucia Marretta, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, et al.
Frontiers in Genetics
|
December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
Sara Parola, Christoph Oing, Pasquale Rescigno, et al.
Clinical Genitourinary Cancer
|
May 7, 2021
Assessment of Total, PTEN<sup>-</sup>, and AR-V7<sup>+</sup> Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
Giuseppe Di Lorenzo, Silvia Zappavigna, Felice Crocetto, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2020
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
Margaret Ottaviano, Marcello Curvietto, Pasquale Rescigno, et al.
Page
of 1